Announced Fri, 15 May · 20:38 IST

General Insurance Corporation of India has informed the Exchange regarding 'In Principle Approval For Infusion Of Funds Into The Corporation S Labuan (Malaysia) Branch'.

Business Updates View source PDF

GICRE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹387.95
prior close
₹387.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-1.3-2.1-2.0+0.0+0.0-0.8-1.7+1.1+0.5+0.0-8.0-7.3
Up moveDown movePending
AI summary

General Insurance Corporation of India (GIC Re) has received in-principle approval from its Board of Directors to infuse USD 49 million (approximately Rs 469 crore) into its Labuan (Malaysia) branch. The capital infusion is intended for solvency restoration and is in line with the Insurance Capital Adequacy Framework guidelines set by the Labuan Financial Services Authority (LFSA). The Board meeting was held on 15th May 2026 and lasted about an hour. The final infusion is contingent upon receiving necessary regulatory approvals and completing requisite formalities.

Likely market impact

This capital infusion strengthens the solvency position of GIC Re's overseas branch, ensuring regulatory compliance in Malaysia. While it involves outflow of funds from the parent company, it is a positive regulatory development that addresses a compliance requirement and may support the company's international operations.